Cited by 187Dementia and Cognitive Impairment ResearchDiabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels: A Randomized Clinical Trial

Open access

Williamson, Jeff D., Launer, Lenore J., Bryan, R. Nick, Coker, Laura H., Lazar, Ronald M., Gerstein, Hertzel C., Murray, Anne M., Sullivan, Mark D., Horowitz, Karen R., Ding, Jingzhong, Marcovina, Santica, Lovato, Laura, Lovato, James, Margolis, Karen L., Davatzikos, Christos, Barzilay, Joshua, Ginsberg, Henry N., Linz, Peter E., Miller, Michael E.·2014·JAMA Internal Medicine

DOI 10.1001/jamainternmed.2013.13656PMC PMC4423790

Open this paper in CoChat — free account

Abstract

IMPORTANCE: Persons with type 2 diabetes mellitus (T2DM) are at increased risk for decline in cognitive function, reduced brain volume, and increased white matter lesions in the brain. Poor control of blood pressure (BP) and lipid levels are risk factors for T2DM-related cognitive decline, but the effect of intensive treatment on brain function and structure is unknown. OBJECTIVE: To examine whether intensive therapy for hypertension and combination therapy with a statin plus a fibrate reduces the risk of decline in cognitive function and total brain volume (TBV) in patients with T2DM. DESIGN, SETTING, AND PARTICIPANTS: A North American multicenter clinical trial including 2977 participants without baseline clinical evidence of cognitive impairment or dementia and with hemoglobin A1c (HbA1c) levels less than 7.5% randomized to a systolic BP goal of less than 120 vs less than 140 mm Hg (n = 1439) or to a fibrate vs placebo in patients with low-density lipoprotein cholesterol levels less than 100 mg/dL (n = 1538). Participants were recruited from August 1, 2003, through October 31, 2005, with the final follow-up visit by June 30, 2009. MAIN OUTCOME MEASURES: Cognition was assessed at baseline and 20 and 40 months. A subset of 503 participants underwent baseline and 40-month brain magnetic resonance imaging to assess for change in TBV and other structural measures of brain health. RESULTS: Baseline mean HbA1c level was 8.3%; mean age, 62 years; and mean duration of T2DM, 10 years. At 40 months, no differences in cognitive function were found in the intensive BP-lowering trial or in the fibrate trial. At 40 months, TBV had declined more in the intensive vs standard BP-lowering group (difference, -4.4 [95% CI, -7.8 to -1.1] cm(3); P = .01). Fibrate therapy had no effect on TBV compared with placebo. CONCLUSIONS AND RELEVANCE: In participants with long-standing T2DM and at high risk for cardiovascular events, intensive BP control and fibrate therapy in the presence of controlled low-density lipoprotein cholesterol levels did not produce a measurable effect on cognitive decline at 40 months of follow-up. Intensive BP control was associated with greater decline in TBV at 40 months relative to standard therapy. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00000620.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamainternmed.2013.13656

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
The PHQ-9: Validity of a brief depression severity measure
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016009606.x · Cited by 44,910
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Neuropsychological assessment, 4th ed.
Lezak, M. D., Howieson, D. B., Loring, D. W., Hannay, H. J., & Fischer, J. S. (2004) · Cited by 1,934
Statistics in Medicine — Reporting of Subgroup Analyses in Clinical Trials
Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., & Drazen, J. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr077003 · Cited by 1,445

Flagged first, then by citations

Show all 32 references

Sorted by citations

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citation
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation
Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987
White matter hyperintensities, cognitive impairment and dementia: an update
Prins, N. D., & Scheltens, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.10 · Cited by 1,284
Untitled work
Williamson (2019) · doi:10.1001/jama.2018.21442 · Cited by 1,246
Self-citation
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Self-citation
Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association
Iadecola, C., Yaffe, K., Biller, J., Bratzke, L. C., Faraci, F. M., Gorelick, P. B., Gulati, M., Kamel, H., Knopman, D. S., Launer, L. J., et al. (2016) · Hypertension · doi:10.1161/hyp.0000000000000053 · Cited by 746
Self-citation
Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis
Hughes, D., Judge, C., Murphy, R., Loughlin, E., Costello, M., Whiteley, W., Bosch, J., O’Donnell, M. J., & Canavan, M. (2020) · JAMA · doi:10.1001/jama.2020.4249 · Cited by 472
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions
Nasrallah, I. M., Pajewski, N. M., Auchus, A. P., Chelune, G. J., Cheung, A. K., Cleveland, M. L., Coker, L. H., Crowe, M. G., Cushman, W. C., Cutler, J. A., et al. (2019) · JAMA · doi:10.1001/jama.2019.10551 · Cited by 433
Self-citation
Defining Optimal Brain Health in Adults: A Presidential Advisory From the American Heart Association/American Stroke Association
Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411
Self-citation
Cognitive function in patients with diabetes mellitus: guidance for daily care
Koekkoek, P. S., Kappelle, L. J., van den Berg, E., Rutten, G. E. H. M., & Biessels, G. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70249-2 · Cited by 422
Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians
Qaseem, A., Wilt, T. J., Rich, R., Humphrey, L. L., Frost, J., & Forciea, M. A. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1785 · Cited by 365
Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: A systematic review and meta-analysis
Rensma, S. P., van Sloten, T. T., Launer, L. J., & Stehouwer, C. D. A. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.04.003 · Cited by 326
Self-citation
Vascular Cognitive Impairment (VCI)
Rundek, T., Tolea, M. I., Ariko, T., Fagerli, E. A., & Camargo, C. J. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01170-y · Cited by 347
Brain Changes Underlying Cognitive Dysfunction in Diabetes: What Can We Learn From MRI?
Biessels, G. J., & Reijmer, Y. D. (2014) · Diabetes · doi:10.2337/db14-0348 · Cited by 296
Cognitive dysfunction in older adults with diabetes: what a clinician needs to know
Munshi, M. N. (2017) · Diabetes Care · doi:10.2337/dc16-1229 · Cited by 255
Vascular contributions to cognitive impairment and dementia (VCID): A report from the 2018 National Heart, Lung, and Blood Institute and National Institute of Neurological Disorders and Stroke Workshop
Zloković, B. V., Gottesman, R. F., Bernstein, K. E., Seshadri, S. S., McKee, A. C., Snyder, H. M., Greenberg, S. M., Yaffe, K. S., Schaffer, C. B., Yuan, C., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12157 · Cited by 252
Self-citation
Obesity as a risk factor for Alzheimer's disease: weighing the evidence
Alford, S., Patel, D. K., Perakakis, N., & Mantzoros, C. S. (2017) · Obesity Reviews · doi:10.1111/obr.12629 · Cited by 232
The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors
Feinkohl, I., Price, J. F., Strachan, M. W. J., & Frier, B. M. (2015) · Alzheimer s Research & Therapy · doi:10.1186/s13195-015-0130-5 · Cited by 195
Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia
Fink, H. A., Jutkowitz, E., McCarten, J. R., Hemmy, L. S., Butler, M., Davila, H. W., Ratner, E. R., Calvert, C., Barclay, T. R., Brasure, M., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1529 · Cited by 205
Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: a longitudinal study
Callisaya, M. L., Beare, R. J., Moran, C., Phan, T. G., Wang, W., & Srikanth, V. K. (2018) · Diabetologia · doi:10.1007/s00125-018-4778-9 · Cited by 185
ESO Guideline on covert cerebral small vessel disease
Wardlaw, J. M., Debette, S., Jokinen, H., de Leeuw, F., Pantoni, L., Chabriat, H., Staals, J., Doubal, F., Rudilosso, S., Eppinger, S., et al. (2021) · European Stroke Journal · doi:10.1177/23969873211012132 · Cited by 178
Retracted
Benefits and Harms of Intensive Blood Pressure Treatment in Adults Aged 60 Years or Older
Weiss, J. W., Freeman, M., Low, A., Fu, R., Kerfoot, A., Paynter, R. A., Motu’apuaka, M. L., Kondo, K. K., & Kansagara, D. L. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1754 · Cited by 173
Prediabetes and associated disorders
Buysschaert, M., Medina, J. L., Bergman, M., Shah, A., & Lonier, J. (2014) · Endocrine · doi:10.1007/s12020-014-0436-2 · Cited by 164
Sex Differences in Alzheimer’s Disease
Aggarwal, N. T., & Mielke, M. M. (2023) · Neurologic Clinics · doi:10.1016/j.ncl.2023.01.001 · Cited by 184
Fibrates for primary prevention of cardiovascular disease events
Jakob, T., Nordmann, A. J., Schandelmaier, S., Ferreira-González, I., & Briel, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009753.pub2 · Cited by 147
Risk of Dementia in Seniors With Newly Diagnosed Diabetes: A Population-Based Study
Haroon, N. N., Austin, P. C., Shah, B. R., Wu, J., Gill, S. S., & Booth, G. L. (2015) · Diabetes Care · doi:10.2337/dc15-0491 · Cited by 131
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Candia, S. B., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12320 · Cited by 123
Population Attributable Risks of Hypertension and Diabetes for Cardiovascular Disease and Stroke in the Northern Manhattan Study
Willey, J. Z., Moon, Y. P., Kahn, E. B., Rodríguez, C. J., Rundek, T., Cheung, K., Sacco, R. L., & Elkind, M. S. V. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001106 · Cited by 113
Glucose targets for preventing diabetic kidney disease and its progression
Ruospo, M., Saglimbene, V. M., Palmer, S. C., De Cosmo, S., Pacilli, A., Lamacchia, O., Cignarelli, M., Fioretto, P., Vecchio, M., Craig, J. C., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010137.pub2 · Cited by 111
Diabetes and cognitive function: An evidence-based current perspective
Sebastian, M. J., Khan, S. K. A., Pappachan, J. M., & Jeeyavudeen, M. S. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i2.92 · Cited by 115
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Lo, C., Toyama, T., Wang, Y., Lin, J., Hirakawa, Y., Jun, M., Cass, A., Hawley, C. M., Pilmore, H., Badve, S. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011798.pub2 · Cited by 157
Comparative Proteomic Analysis of the Mitochondria-associated ER Membrane (MAM) in a Long-term Type 2 Diabetic Rodent Model
Hongjie, J., Shen, S., Wang, J. J., He, Z., Poon, A. Y., Li, J., Qu, J., & Zhang, S. X. (2017) · Scientific Reports · doi:10.1038/s41598-017-02213-1 · Cited by 95
Primary and Secondary Prevention Trials in Alzheimer Disease: Looking Back, Moving Forward
Hsu, D. C., & Marshall, G. A. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160930112125 · Cited by 95
Effect of Antihypertensive Medication on Cerebral Small Vessel Disease
van Middelaar, T., Argillander, T. E., Schreuder, F. H. B. M., Deinum, J., Richard, E., & Klijn, C. J. M. (2018) · Stroke · doi:10.1161/strokeaha.118.021160 · Cited by 92
CAP—advancing the evaluation of preclinical Alzheimer disease treatments
Reiman, E. M., Langbaum, J. B. S., Tariot, P. N., Lopera, F. J., Bateman, R. J., Morris, J. C., Sperling, R. A., Aisen, P. S. S., Roses, A. D., Welsh-Bohmer, K. A., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.177 · Cited by 92
Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics
de Havenon, A., Majersik, J. J., Tirschwell, D., McNally, J. S., Stoddard, G. J., & Rost, N. S. (2019) · Neurology · doi:10.1212/wnl.0000000000007093 · Cited by 91
Physical Exercise for Individuals with Hypertension: It Is Time to Emphasize its Benefits on the Brain and Cognition
Rêgo, M. L. D. M., Cabral, D. A. R., Costa, E. C., & Fontes, E. B. (2019) · Clinical Medicine Insights Cardiology · doi:10.1177/1179546819839411 · Cited by 102
The impact of diabetes in cognitive impairment: A review of current evidence and prospects for future investigations
Aderinto, N., Olatunji, G. D., Muili, A. O., Ashinze, P. T., Faturoti, O., Ajagbe͓, A. O., Ukoaka, B. M., & Aboderin, G. (2023) · Medicine · doi:10.1097/md.0000000000035557 · Cited by 100
Metabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches
Clarke, J. R., Ribeiro, F. C., Frozza, R. L., Felice, F. G. D., & Lourenco, M. V. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179911 · Cited by 93
Atrial fibrillation and dementia
Jacobs, V., Cutler, M. J., Day, J. D., & Bunch, T. J. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.002 · Cited by 84
Management of Adults With Diabetes and Cognitive Problems
Hopkins, R. L., Shaver, K., & Weinstock, R. S. (2016) · Diabetes Spectrum · doi:10.2337/ds16-0035 · Cited by 84
Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial
Rapp, S. R., Gaussoin, S. A., Sachs, B. C., Chelune, G. J., Supiano, M. A., Lerner, A. J., Wadley, V. G., Wilson, V. M., Fine, L. J., Whittle, J., et al. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30319-7 · Cited by 85
Self-citation
Associations of the metabolic syndrome and its components with cognitive impairment in older adults
Feinkohl, I., Janke, J., Hadzidiakos, D. A., Slooter, A. J. C., Winterer, G., Spies, C., & Pischon, T. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1073-7 · Cited by 82
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Volgman, A. S., Merz, C. N. B., Aggarwal, N. T., Bittner, V., Bunch, T. J., Gorelick, P. B., Maki, P. M., Patel, H. N., Poppas, A., Ruskin, J. N., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013154 · Cited by 82
Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease
Nasrallah, I. M., Gaussoin, S. A., Pomponio, R., Dolui, S., Erus, G., Wright, C. B., Launer, L. J., Detre, J. A., Wolk, D. A., Davatzikos, C. A., et al. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.0178 · Cited by 72
Self-citation
Intensive LDL-cholesterol lowering therapy and neurocognitive function
Banach, M., Rizzo, M., Nikolić, D., Howard, G., Howard, V. J., & Mikhailidis (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.001 · Cited by 68
Association of Type 2 Diabetes, According to the Number of Risk Factors Within Target Range, With Structural Brain Abnormalities, Cognitive Performance, and Risk of Dementia
van Gennip, A. C. E., Stehouwer, C. D. A., van Boxtel, M. P. J., Verhey, F. R. J., Koster, A., Kroon, A. A., Köhler, S., van Greevenbroek, M. M. J., Wesselius, A., Eussen, S. J. P. M., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0149 · Cited by 58
Abnormal brain white matter microstructure is associated with both pre-hypertension and hypertension
Suzuki, H., Gao, H., Bai, W., Εvangelou, Ε., Glocker, B., O’Regan, D. P., Elliott, P., & Matthews, P. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187600 · Cited by 62
Blood Pressure and Vascular Cognitive Impairment
Levine, D. A., Springer, M. V., & Brodtmann, A. G. (2022) · Stroke · doi:10.1161/strokeaha.121.036140 · Cited by 63
Feasibility of a multi-modal exercise program on cognition in older adults with Type 2 diabetes – a pilot randomised controlled trial
Callisaya, M. L., Daly, R. M., Sharman, J. E., Bruce, D. G., Davis, T. M. E., Greenaway, T. M., Nolan, M. T., Beare, R. J., Schultz, M. G., Phan, T. G., et al. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0635-9 · Cited by 54
Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients
Scott, I. A., Hilmer, S. N., & Couteur, D. G. L. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00683-8 · Cited by 55
Risk Factors, Lifestyle Behaviors, and Vascular Brain Health
Gottesman, R. F., & Seshadri, S. S. (2022) · Stroke · doi:10.1161/strokeaha.121.032610 · Cited by 53
Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis
Gupta, A., Perdomo, S. J., Billinger, S. A., Beddhu, S., Burns, J. M., & Gronseth, G. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038971 · Cited by 51
Optogenetic Stimulation of mPFC Alleviates White Matter Injury‐Related Cognitive Decline after Chronic Ischemia through Adaptive Myelination
Deng, S., Shu, S., Zhai, L., Xia, S., Cao, X., Li, H., Bao, X., Liu, P., & Xu, Y. (2022) · Advanced Science · doi:10.1002/advs.202202976 · Cited by 45
Poorly controlled cholesterol is associated with cognitive impairment in T2DM: a resting-state fMRI study
Xia, W., Zhang, B., Yang, Y., Wang, P., Yang, Y., & Wang, S. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0046-x · Cited by 42
The pleiotropic vasoprotective functions of high density lipoproteins (HDL)
Boyce, G. K., Button, E. B., Sonja, S. V., & Wellington, C. L. (2017) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160103 · Cited by 41
Effects of Antihypertensive Drugs on Cognitive Function in Elderly Patients with Hypertension: A Review
Yang, W., Luo, H., Ma, Y., Si, S.-C., & Zhao, H. (2021) · Aging and Disease · doi:10.14336/ad.2020.1111 · Cited by 46
Diabetes, but Not Hypertension and Obesity, Is Associated with Postoperative Cognitive Dysfunction
Lachmann, G., Feinkohl, I., Borchers, F., Ottens, T. H., Nathoe, H. M., Sauër, A.-M. C., Dieleman, J. M., Radtke, F. M., van Dijk, D., Spies, C., et al. (2018) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000492962 · Cited by 40
The factors contributing to cognitive dysfunction in type 2 diabetic patients
Xia, S.-S., Xia, W.-L., Huang, J., Zou, H., Tao, J., & Yang, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.113 · Cited by 43
MRI-based biomarkers of accelerated aging and dementia risk in midlife: how close are we?
Elliott, M. L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101075 · Cited by 39
Hypertensive Exposure Markers by MRI in Relation to Cerebral Small Vessel Disease and Cognitive Impairment
Amier, R. P., Marcks, N., Hooghiemstra, A. M., Nijveldt, R., van Buchem, M. A., Roos, A., Biessels, G. J., Kappelle, L. J., van Oostenbrugge, R. J., van der Geest, R. J., et al. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.06.040 · Cited by 39
p38 MAPK Inhibition Improves Synaptic Plasticity and Memory in Angiotensin II-dependent Hypertensive Mice
Dai, H., Hu, W.-Y., Jiang, L.-H., Li, L., Gaung, X., & Xiao, Z. (2016) · Scientific Reports · doi:10.1038/srep27600 · Cited by 38
Caloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed mice
Kim, H., Kang, H., Heo, R. W., Jeon, B. T., Yi, C., Shin, H. J., Kim, J., Jeong, S., Kwak, W., Kim, W., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606724 · Cited by 37
Risk factors for cognitive impairment in older people with diabetes: a community-based study
Xiu, S., Liao, Q., Sun, L., & Chan, P. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819836640 · Cited by 39
Associations between vascular risk factors and subsequent Alzheimer’s disease in older adults
Lee, H., Kim, K., Lee, Y. C., Kim, S., Won, H., Yu, T. Y., Lee, E. M., Kang, J. M., Lewis, M., Kim, D. K., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00690-7 · Cited by 39
Plasma metabolomic signature of healthy lifestyle, structural brain reserve and risk of dementia
Tian, F., Wang, Y., Qian, Z. M., Ran, S., Zhang, Z., Wang, C., McMillin, S. E., Chavan, N. R., & Lin, H. (2024) · Brain · doi:10.1093/brain/awae257 · Cited by 37
Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results
Mahinrad, S., Sorond, F. A., & Gorelick, P. B. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2204148 · Cited by 34
Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter Hyperintensities
Huang, W.-Q., Lin, Q., & Tzeng, C. (2024) · Journal of Stroke · doi:10.5853/jos.2023.02719 · Cited by 35
Cardiovascular risk factors and cognitive decline in older people with type 2 diabetes
Feinkohl, I., Keller, M., Robertson, C. M., Morling, J. R., McLachlan, S., Frier, B. M., Deary, I. J., Strachan, M. W. J., & Price, J. F. (2015) · Diabetologia · doi:10.1007/s00125-015-3581-0 · Cited by 30
Evaluation of Intensive vs Standard Blood Pressure Reduction and Association With Cognitive Decline and Dementia
Dallaire‐Théroux, C., Quesnel‐Olivo, M., Brochu, K., Bergeron, F., O'Connor, S. E., Turgeon, A. F., Laforce, R. J., Verreault, S., Camden, M., & Duchesne, S. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.34553 · Cited by 29
Hypertension management in older adults
Bilen, O., & WENGER, N. K. (2020) · F1000Research · doi:10.12688/f1000research.20323.1 · Cited by 30
Sex differences in risk factors for cognitive decline and dementia, including death as a competing risk, in individuals with diabetes: Results from the ADVANCE trial
Gong, J., Harris, K., Hackett, M. L., Peters, S. A. E., Brodaty, H., Cooper, M. E., Hamet, P., Harrap, S. B., Mancia, G., MacMahon, S. W., et al. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14391 · Cited by 31
Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes
Raffield, L. M., Brenes, G. A., Cox, A. J., Freedman, B. I., Hugenschmidt, C. E., Hsu, F., Xu, J., Wagner, B., Williamson, J. D., Maldjian, J. A., et al. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.010 · Cited by 27
Self-citation
The relation between antihypertensive treatment and progression of cerebral small vessel disease
Su, C., Wu, H., Yang, X., Zhao, B. T., & Zhao, R. (2021) · Medicine · doi:10.1097/md.0000000000026749 · Cited by 28
Subclinical Cerebrovascular Disease: Epidemiology and Treatment
de Havenon, A., Meyer, C., McNally, J. S., Alexander, M. D., & Chung, L. S. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0799-1 · Cited by 26
Blood Pressure and the Prevention of Cognitive Impairment
Gorelick, P. B. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2014 · Cited by 26
Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
Cunningham, E. L., Todd, S. A., Passmore, P., Bullock, R., & McGuinness, B. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004034.pub4 · Cited by 45
Characteristics of Populations Excluded From Clinical Trials Supporting Intensive Blood Pressure Control Guidelines
Anderson, T. S., Odden, M. C., Penko, J. M., Kazi, D. S., Bellows, B. K., & Bibbins-Domingo, K. B. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019707 · Cited by 26
A novel palmitic acid hydroxy stearic acid (5‐PAHSA) plays a neuroprotective role by inhibiting phosphorylation of the m‐TOR‐ULK1 pathway and regulating autophagy
Wang, J., Yu, Z., Tao, Y., Liu, Y., Wang, Y., Guo, Q., Xue, J., Wen, X., Zhang, Q., Xu, X., et al. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13573 · Cited by 23
The Role of Vascular Risk Factors in Cognitive Impairment and Dementia and Prospects for Prevention
Mahinrad, S., Sorond, F. A., & Gorelick, P. B. (2022) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2022.07.007 · Cited by 25
Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine
Valencia, W. M., Botros, D., Vera-Nunez, M. A., & Dang, S. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1052-y · Cited by 26
Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
Salama, I. I., Sami, S. M., Elshaarawy, G. A., Mohsen, A., Attia, H., Kamel, S. A., Ibrahim, M. H., Mostafa, M., Fouad, W. A., & Raslan, H. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0236453 · Cited by 22
Hypertensive Aspects of Cardiometabolic Disorders Are Associated with Lower Brain Microstructure, Perfusion, and Cognition
Hughes, T. M., Lockhart, S. N., Suerken, C. K., Jung, Y., Whitlow, C. T., Bateman, J. R., Williams, B. J., Espeland, M. A., Sachs, B. C., Williamson, J. D., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220646 · Cited by 22
Self-citation
Effect of intensive versus standard blood pressure control on cardiovascular outcomes in adult patients with hypertension: a systematic review and meta-analysis
Haze, T., Katsurada, K., Sakata, S., Kuwabara, M., Nishida, N., Azegami, T., Sakima, A., & Kai, H. (2025) · Hypertension Research · doi:10.1038/s41440-025-02131-0 · Cited by 19
ORGANIZING NUTRITION OF SCHOOLCHILDREN: PROBLEMS AND SOLUTIONS
Tapeshkina, N. V., Pochueva, L. P., & Петровна, В. О. (2019) · Fundamental and Clinical Medicine · doi:10.23946/2500-0764-2019-4-2-120-128 · Cited by 19
Association Between the Frailty and Cognitive Impairment Among Patients With Hypertension—A Post Hoc Analysis of the SPRINT Trial
Wang, Z., Wang, Q., Pei, J., Wang, X., Li, Y., Yan, J., & Du, X. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.028736 · Cited by 19
How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection?
Aung, H. L., Kootar, S., Gates, T. M., Brew, B. J., & Cysique, L. A. (2019) · European Geriatric Medicine · doi:10.1007/s41999-019-00164-6 · Cited by 20
Long-term levels of LDL-C and cognitive function: the CARDIA study
Mefford, M. T., Chen, L., Lewis, C. E., Muntner, P., Sidney, S., Launer, L. J., Monda, K. L., Ruzza, A., Kassahun, H., Rosenson, R. S., et al. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721000059 · Cited by 15
Self-citation
Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?
Kuang, Z.-M. (2020) · Cardiology Research and Practice · doi:10.1155/2020/1484357 · Cited by 19
Cognitive decline and T2DM—a disconnect in the evidence?
Strachan, M. W. J., & Price, J. F. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.38 · Cited by 16
Relationships between cerebral structure and cognitive function in African Americans with type 2 diabetes
Hughes, T. M., Sink, K. M., Williamson, J. D., Hugenschmidt, C. E., Wagner, B., Whitlow, C. T., Xu, J., Smith, S. C., Launer, L. J., Barzilay, J. I., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.05.017 · Cited by 16
Self-citation
Should Hypertension Be Treated in Late Life to Preserve Cognitive Function?
Gottesman, R. F. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.09336 · Cited by 16
Predictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial
Zimering, M. B., Knight, J., Ge, L., & Bahn, G. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00123 · Cited by 15
Venous dysfunction plays a critical role in “normal” white matter disease of aging
Kapadia, A. N., & Dmytriw, A. A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110457 · Cited by 15
New Horizons—Cognitive Dysfunction Associated With Type 2 Diabetes
Moran, C., Than, S., Callisaya, M. L., Beare, R. J., & Srikanth, V. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab797 · Cited by 15
Perspectives on the relation of blood pressure and cognition in the elderly
Goshgarian, C., & Gorelick, P. B. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.05.011 · Cited by 13
Intensive versus standard blood pressure control in type 2 diabetes: a restricted mean survival time analysis of a randomised controlled trial
Shi, S., Gouskova, N., Najafzadeh, M., Wei, L., & Kim, D. H. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050335 · Cited by 12
Correction: Plasma microRNAs biomarkers in mild cognitive impairment among patients with type 2 diabetes mellitus
Salama, I. I., Sami, S. M., Elshaarawy, G. A., Mohsen, A., Rasmy, H., Kamel, S. A., Ibrahim, M. H., Ganem, M. M. F., Fouad, W. A., & Raslan, H. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243177 · Cited by 11
Research progress on risk factors of delirium in burn patients: A narrative review
Ren, Y., Zhang, Y., Luo, J., Liao, W., Cheng, X., & Zhan, J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.989218 · Cited by 13

Authors: Williamson, J. D., Launer, L. J., Bryan, R. N., Coker, L. H., Lazar, R. M., Gerstein, H. C., Murray, A. M., Sullivan, M. D., Horowitz, K. R., Ding, J., Marcovina, S., Lovato, L., Lovato, J., Margolis, K. L., Davatzikos, C., Barzilay, J., Ginsberg, H. N., Linz, P. E., & Miller, M. E.
Affiliations: Wake Forest University Health Sciences (US)
National Institutes of Health (US)
University of Pennsylvania Health System (US)
Columbia University Irving Medical Center (US)
Population Health Research Institute (CA)
Hennepin County Medical Center (US)
University of Washington (US)
Case Western Reserve University (US)
University of Minnesota (US)
Kaiser Permanente (US)
Naval Medical Center San Diego (US)
Corresponding author: Williamson, Jeff D.
ORCID: Williamson, Jeff D.
Launer, Lenore J.
Bryan, R. Nick
Lazar, Ronald M.
Gerstein, Hertzel C.
Murray, Anne M.
Sullivan, Mark D.
Ding, Jingzhong
Marcovina, Santica
Lovato, James
Margolis, Karen L.
Davatzikos, Christos
Barzilay, Joshua
Ginsberg, Henry N.
Miller, Michael E.
Venue: JAMA Internal Medicine
Publisher: American Medical Association (AMA)
Published: 2014-03-01
Volume: 174
Issue: 3
Pages: 324
ISSN: 2168-6106 (ISSN-L)
DOI: 10.1001/jamainternmed.2013.13656
PMC: PMC4423790
OpenAlex: W2110109090
Cited by: 187
References: 32
Citations by year: 2026: 6 · 2025: 12 · 2024: 7 · 2023: 12 · 2022: 9 · 2021: 19 · 2020: 15 · 2019: 28 · 2018: 19 · 2017: 19 · 2016: 11 · 2015: 16 · 2014: 13
FWCI: 15.00
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA Internal Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Heart, Lung, and Blood Institute (HHSN268201100027C)
National Institute of General Medical Sciences (U54GM104940)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: type 2 diabetes, cognitive decline, total brain volume, brain structure, intensive blood pressure control, systolic blood pressure, fibrate therapy, statin therapy, LDL cholesterol, white matter lesions, cognitive function, brain atrophy, hypertension, lipid-lowering therapy, dementia risk
MeSH terms: Aged, Antihypertensive Agents, Blood Pressure, Brain, Cognition, Diabetes Mellitus, Type 2, Female, Humans, Hypercholesterolemia, Hypertension, Lipids, Magnetic Resonance Imaging, Male, Middle Aged, Risk Factors, Treatment Outcome, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels: A Randomized Clinical Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks